Sustaining & Accelerating Research for ROS1 Cancer
In October of 2020, The ROS1ders held the first research roundtable to discuss ROS1+ cancer research opportunities and prioritize ways The ROS1ders can help accelerate research for
our disease. The meeting consisted of a group of international clinicians, researchers, patients, and caregivers experienced in ROS1+ cancer.
The event was recorded and summarized in the following White Paper.
The white paper was translated into German, French, Spanish and Japanese to make it accessible to more patients, caregivers, clinicians, and researchers around the world.
If you want to support The ROS1ders' work, please consider a donation today.